Cardiovascular and Metabolic Disease: New Treatment and Future Directions—The 3rd Edition
1. Introduction
2. Overview of Published Articles
2.1. Biomarkers and Molecular Mechanisms
2.2. Cardiometabolic and Endocrine Disorders
2.3. Diagnostic Imaging and Interventional Techniques
2.4. Epidemiology, Population Studies, and Public Health
2.5. Translational and Experimental Medicine
3. Therapeutic Innovations and Pharmacological Strategies
4. Systematic Reviews and Meta-Analyses
5. Future Perspectives
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
List of Contributions
- Berezin, A.E.; Berezina, T.A.; Novikov, E.V.; Berezin, O.O. Serum Levels of Irisin Are Positively Associated with Improved Cardiac Function in Patients with Heart Failure with Reduced Ejection Fraction. Biomedicines 2025, 13, 866. https://doi.org/10.3390/biomedicines13040866.
- Martínez-García, I.; Saz-Lara, A.; Pascual-Morena, C.; Díez-Fernández, A.; Valladolid-Ayllón, S.; Bizzozero-Peroni, B.; Martínez-Cifuentes, Ó.; Rodríguez-Gutiérrez, E.; Cavero-Redondo, I. Role of Advanced Glycation End Products in Mediating Glycated Haemoglobin and Pulse Wave Velocity in Healthy Adults. Biomedicines 2025, 13, 137. https://doi.org/10.3390/biomedicines13010137.
- Ellis, C.P.S.; Tero, B.W.; Potts, C.M.; Malka, K.T.; Yang, X.; Hamilton, J.; Vary, C.; Khalil, A.; Liaw, L. Cellular Characteristics and Protein Signatures of Human Adipose Tissues from Donors With or Without Advanced Coronary Artery Disease. Biomedicines 2024, 12, 2453. https://doi.org/10.3390/biomedicines12112453.
- Awad, K.; Kakkola, L.; Julkunen, I. High Glucose Increases Lactate and Induces the Transforming Growth Factor Beta-Smad 1/5 Atherogenic Pathway in Primary Human Macrophages. Biomedicines 2024, 12, 1575. https://doi.org/10.3390/biomedicines12071575.
- Cooper, I.D.; Kyriakidou, Y.; Petagine, L.; Edwards, K.; Soto-Mota, A.; Brookler, K.; Elliott, B.T. Ketosis Suppression and Ageing (KetoSAge) Part 2: The Effect of Suppressing Ketosis on Biomarkers Associated with Ageing, HOMA-IR, Leptin, Osteocalcin, and GLP-1, in Healthy Females. Biomedicines 2024, 12, 1553. https://doi.org/10.3390/biomedicines12071553.
- Nandakumar, M.; Sathyapalan, T.; Atkin, S.L.; Butler, A.E. Effect of Hypoglycemia and Rebound Hyperglycemia on Proteomic Cardiovascular Risk Biomarkers. Biomedicines 2024, 12, 1137. https://doi.org/10.3390/biomedicines12061137.
- Eccles-Miller, J.A.; Johnson, T.D.; Baldwin, W.S. Sexually Dimorphic Effects of CYP2B6 in the Development of Fasting-Mediated Steatosis in Mice: Role of the Oxylipin Products 9-HODE and 9-HOTrE. Biomedicines 2025, 13, 295. https://doi.org/10.3390/biomedicines13020295.
- Soukop, J.; Kazdová, L.; Hüttl, M.; Malínská, H.; Marková, I.; Oliyarnyk, O.; Miklánková, D.; Gurská, S.; Rácová, Z.; Poruba, M.; et al. Beneficial Effect of Fenofibrate in Combination with Silymarin on Parameters of Hereditary Hypertriglyceridemia-Induced Disorders in an Animal Model of Metabolic Syndrome. Biomedicines 2025, 13, 212. https://doi.org/10.3390/biomedicines13010212.
- Sági, B.; Vas, T.; Csiky, B.; Nagy, J.; Kovács, T.J. Does Metabolic Syndrome and Its Components Have Prognostic Significance for Renal and Cardiovascular Outcomes in IgA Nephropathy? Biomedicines 2024, 12, 1250. https://doi.org/10.3390/biomedicines12061250.
- Yan, R.; Cao, Y. The Safety and Efficacy of Dietary Epigallocatechin Gallate Supplementation for the Management of Obesity and Non-Alcoholic Fatty Liver Disease: Recent Updates. Biomedicines 2025, 13, 206. https://doi.org/10.3390/biomedicines13010206.
- Sztanek, F.; Tóth, L.I.; Pető, A.; Hernyák, M.; Diószegi, Á.; Harangi, M. New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists. Biomedicines 2024, 12, 1320. https://doi.org/10.3390/biomedicines12061320.
- Nesci, S.; Rubattu, S. UCP2, a Member of the Mitochondrial Uncoupling Proteins: An Overview from Physiological to Pathological Roles. Biomedicines 2024, 12, 1307. https://doi.org/10.3390/biomedicines12061307.
- Wańczura, P.; Mytych, W.; Bartusik-Aebisher, D.; Leksa, D.; Truszkiewicz, A.; Aebisher, D. Visualization of Atherosclerotic Plaques Paired with Joheksol 350 (Omnipaque). Biomedicines 2025, 13, 399. https://doi.org/10.3390/biomedicines13020399.
- Kim, N.; Hwang, H.-J.; Yang, I.-H. Assessing Cardiovascular Risk with Coronary Artery Calcium and Carotid Intima-Media Thickness in Patients with Negative Stress Echocardiography. Biomedicines 2024, 12, 2151. https://doi.org/10.3390/biomedicines12092151.
- Chlupac, J.; Frank, J.; Sedmera, D.; Fabian, O.; Simunkova, Z.; Mrazova, I.; Novak, T.; Vanourková, Z.; Benada, O.; Pulda, Z.; et al. External Support of Autologous Internal Jugular Vein Grafts with FRAME Mesh in a Porcine Carotid Artery Model. Biomedicines 2024, 12, 1335. https://doi.org/10.3390/biomedicines12061335.
- Zdebik, N.; Poręba, R.; Gać, P. Importance of T1-Mapping Sequence in Patients with Hypertrophic Cardiomyopathy without Foci of Non-Ischemic Myocardial Injury in Late Gadolinium Enhancement Sequence. Biomedicines 2024, 12, 1330. https://doi.org/10.3390/biomedicines12061330.
- Gil, R.J.; Kern, A.; Bojko, K.; Gziut-Rudkowska, A.; Vassilev, D.; Bil, J. The Randomized, Multicenter, Open-Label, Controlled POLBOS 3 Trial Comparing Regular Drug-Eluting Stents and the Sirolimus-Eluting BiOSS LIM C Dedicated Coronary Bifurcation Stent: Four-Year Results. Biomedicines 2024, 12, 938. https://doi.org/10.3390/biomedicines12050938.
- Šileikienė, V.; Dženkevičiūtė, V.; Čypienė, A.; Šlapikas, T.; Puronaitė, R.; Badarienė, J.; Laucevičius, A.; Butkevičiūtė, E.; Rinkūnienė, E. Analysis of Cardiovascular High-Risk Profile in Middle-Aged Lithuanian Men with Arterial Hypertension from 2009 to 2019. Biomedicines 2025, 13, 272. https://doi.org/10.3390/biomedicines13020272.
- Boxhammer, E.; Hammerer, M.; Schernthaner, C.; Prinz, E.; Brandt, M.C.; Lichtenauer, M.; Berezin, A.E.; Wintersteller, W.; Hoppe, U.C.; Kopp, K.L. The Silent Threat: A Retrospective Cohort Study on the Impact of Prediabetes on ST-Elevation Myocardial Infarction Survival—A Call to Action! Biomedicines 2024, 12, 2223. https://doi.org/10.3390/biomedicines12102223.
- Volpentesta, M.; Condoleo, V.; Panza, A.; Severini, G.; Soraci, L.; Rotondo, C.; Armentaro, G.; Pelaia, C.; Fiorentino, V.T.; Andreozzi, F.; et al. Effects of Continuous Positive Airway Pressure Treatment on Vascular Function in a Real-Life Cohort of Elderly Patients with Obstructive Sleep Apnoea Syndrome. Biomedicines 2024, 12, 2563. https://doi.org/10.3390/biomedicines12112563.
- Angom, R.S.; Nakka, N.M.R. Zebrafish as a Model for Cardiovascular and Metabolic Disease: The Future of Precision Medicine. Biomedicines 2024, 12, 693. https://doi.org/10.3390/biomedicines12030693.
- Nie, Y.; Lin, L.; Yang, Q.; Hu, J.; Sun, M.; Xiang, F.; Cao, X.; Yu, J.; Wang, Y.; Teng, J.; et al. Mitochondrial Dysfunction and Ion Imbalance in a Rat Model of Hemodialysis-Induced Myocardial Stunning. Biomedicines 2024, 12, 2402. https://doi.org/10.3390/biomedicines12102402.
- Popescu, A.I.; Rață, A.L.; Vlad, D.; Vlad, C.; Popescu, R.; Onofrei, R.R.; Morelli, M.; Pantea, S.; Barac, S. miRNA in the Diagnosis and Treatment of Critical Limb Ischemia. Biomedicines 2024, 12, 2026. https://doi.org/10.3390/biomedicines12092026.
- Pavlatos, N.; Kalra, D.K. The Role of Lipoprotein(a) in Peripheral Artery Disease. Biomedicines 2024, 12, 1229. https://doi.org/10.3390/biomedicines12061229.
- Ogurtsova, E.; Arefieva, T.; Filatova, A.; Radyukhina, N.; Ovchinnikov, A. Cardiometabolic Phenotype in HFpEF: Insights from Murine Models. Biomedicines 2025, 13, 744. https://doi.org/10.3390/biomedicines13030744.
- Arnautu, D.-A.; Cozma, D.; Lala, I.-R.; Arnautu, S.-F.; Tomescu, M.-C.; Andor, M. Risk Assessment and Personalized Treatment Options in Inherited Dilated Cardiomyopathies: A Narrative Review. Biomedicines 2024, 12, 1643. https://doi.org/10.3390/biomedicines12081643.
- Profili, N.I.; Castelli, R.; Manetti, R.; Sircana, M.C.; Pagni, M.; Sechi, G.L.; Gidaro, A.; Cossu, C.; Bella, F.; Delitala, A.P. Sodium–Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction. Biomedicines 2025, 13, 720. https://doi.org/10.3390/biomedicines13030720.
- Katsi, V.; Manta, E.; Fragoulis, C.; Tsioufis, K. Weight Loss Therapies and Hypertension Benefits. Biomedicines 2024, 12, 2293. https://doi.org/10.3390/biomedicines12102293.
- Murai, K.; Vasigh, A.; Alexy, T.; Tóth, K.; Czopf, L. The Role of Ranolazine in the Treatment of Ventricular Tachycardia and Atrial Fibrillation: A Narrative Review of the Clinical Evidence. Biomedicines 2024, 12, 1669. https://doi.org/10.3390/biomedicines12081669.
- Kolben, Y.; Gork, I.; Peled, D.; Amitay, S.; Moshel, P.; Goldstein, N.; Ben Ishay, A.; Fons, M.; Tabi, M.; Eisenkraft, A.; et al. Continuous Monitoring of Advanced Hemodynamic Parameters during Hemodialysis Demonstrated Early Variations in Patients Experiencing Intradialytic Hypotension. Biomedicines 2024, 12, 1177. https://doi.org/10.3390/biomedicines12061177.
- Tarasova, I.; Kukhareva, I.; Kupriyanova, D.; Temnikova, T.; Gorbatovskaya, E.; Trubnikova, O. Electrical Activity Changes and Neurovascular Unit Markers in the Brains of Patients after Cardiac Surgery: Effects of Multi-Task Cognitive Training. Biomedicines 2024, 12, 756. https://doi.org/10.3390/biomedicines12040756.
- Piccirillo, G.; Moscucci, F.; Mezzadri, M.; Caltabiano, C.; Cisaria, G.; Vizza, G.; De Santis, V.; Giuffrè, M.; Stefano, S.; Scinicariello, C.; et al. Artificial Intelligence Applied to Electrical and Non-Invasive Hemodynamic Markers in Elderly Decompensated Chronic Heart Failure Patients. Biomedicines 2024, 12, 716. https://doi.org/10.3390/biomedicines12040716.
- Aminuddin, A.; Samah, N.; Che Roos, N.A.; Mohamad, S.F.; Beh, B.C.; A. Hamid, A.; Ugusman, A. Prognostic Value of Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 for Future Cardiovascular Disease Risk and Outcome: A Systematic Review and Meta-Analysis. Biomedicines 2025, 13, 444. https://doi.org/10.3390/biomedicines13020444.
- Buz, B.-F.; Negrean, R.A.; Caruntu, F.; Parvanescu, T.; Slovenski, M.; Tomescu, M.C.; Arnautu, D.-A. Systematic Review of Left Ventricular Remodeling in Response to Hypoglycemic Medications: Assessing Changes in End-Systolic and End-Diastolic Diameters. Biomedicines 2024, 12, 1791. https://doi.org/10.3390/biomedicines12081791.
References
- Dong, X.; Wang, J.; Wang, C.; Wang, B.; Li, G.; Yang, J.; Zou, T. Worldwide Burden of Metabolic Risk-Related Cardiovascular Disease from 1990 to 2021, with Projections to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021. Diabetes Obes. Metab. 2025. Early View. [Google Scholar] [CrossRef] [PubMed]
- Roth, G.A.; Mensah, G.A.; Johnson, C.O.; Addolorato, G.; Ammirati, E.; Baddour, L.M.; Barengo, N.C.; Beaton, A.Z.; Benjamin, E.J.; Benziger, C.P.; et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update from the GBD 2019 Study. J. Am. Coll. Cardiol. 2020, 76, 2982–3021. [Google Scholar] [CrossRef] [PubMed]
- Saeedi, P.; Petersohn, I.; Salpea, P.; Malanda, B.; Karuranga, S.; Unwin, N.; Colagiuri, S.; Guariguata, L.; Motala, A.A.; Ogurtsova, K.; et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 2019, 157, 107843. [Google Scholar] [CrossRef] [PubMed]
- Leon, B.M.; Maddox, T.M. Diabetes and Cardiovascular Disease: Epidemiology, Biological Mechanisms, Treatment Recommendations and Future Research. World J. Diabetes 2015, 6, 1246–1258. [Google Scholar] [CrossRef] [PubMed]
- Wang, Z.; Chen, J.; Zhu, L.; Jiao, S.; Chen, Y.; Sun, Y. Metabolic Disorders and Risk of Cardiovascular Diseases: A Two-Sample Mendelian Randomization Study. BMC Cardiovasc. Disord. 2023, 23, 529. [Google Scholar] [CrossRef] [PubMed]
- Ng, R.; Sutradhar, R.; Yao, Z.; Wodchis, W.P.; Rosella, L.C. Smoking, Drinking, Diet and Physical Activity—Modifiable Lifestyle Risk Factors and Their Associations with Age to First Chronic Disease. Int. J. Epidemiol. 2020, 49, 113–130. [Google Scholar] [CrossRef] [PubMed]
- Nevola, R.; Alfano, M.; Pafundi, P.C.; Brin, C.; Gragnano, F.; Calabrò, P.; Adinolfi, L.E.; Rinaldi, L.; Sasso, F.C.; Caturano, A. Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in the Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease. Rev. Cardiovasc. Med. 2022, 23, 106. [Google Scholar] [CrossRef] [PubMed]
- Ferhatbegović, L.; Mršić, D.; Macić-Džanković, A. The Benefits of GLP1 Receptors in Cardiovascular Diseases. Front. Clin. Diabetes Healthc. 2023, 4, 1293926. [Google Scholar] [CrossRef] [PubMed]
- Holmes, D.R., Jr.; Alkhouli, M. Past, Present, and Future of Interventional Cardiology. J. Am. Coll. Cardiol. 2020, 75, 2738–2743. [Google Scholar] [CrossRef] [PubMed]
- Giugni, F.R.; Berry, J.D.; Khera, A.; Shah, A.M.; de Lemos, J.A. Precision Medicine for Cardiovascular Prevention and Population Health: A Bridge Too Far? Circulation 2024, 150, 1720–1731. [Google Scholar] [CrossRef] [PubMed]
- Galiero, R.; Caturano, A.; Vetrano, E.; Monda, M.; Marfella, R.; Sardu, C.; Salvatore, T.; Rinaldi, L.; Sasso, F.C. Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations. Diabetes Metab. Syndr. Obes. 2023, 16, 3669–3689. [Google Scholar] [CrossRef] [PubMed]
- Geocadin, R.G. Moving Beyond One-Size-Fits-All Treatment for Patients After Cardiac Arrest. JAMA Netw. Open 2020, 3, e208809. [Google Scholar] [CrossRef] [PubMed]
- Hussen, B.M.; Taheri, M.; Yashooa, R.K.; Abdullah, G.H.; Abdullah, S.R.; Kheder, R.K.; Mustafa, S.A. Revolutionizing Medicine: Recent Developments and Future Prospects in Stem-Cell Therapy. Int. J. Surg. 2024, 110, 8002–8024. [Google Scholar] [CrossRef] [PubMed]
- Liao, Y.; Thompson, C.; Peterson, S.; Mandrola, J.; Beg, M.S. The Future of Wearable Technologies and Remote Monitoring in Health Care. Am. Soc. Clin. Oncol. Educ. Book 2019, 39, 115–121. [Google Scholar] [CrossRef] [PubMed]
- Russo, V.; Bottino, R.; Rago, A.; Papa, A.A.; Liccardo, B.; Proietti, R.; Manna, V.; Golino, P.; D’Onofrio, A.; Nigro, G. The Effect of Sacubitril/Valsartan on Device Detected Arrhythmias and Electrical Parameters among Dilated Cardiomyopathy Patients with Reduced Ejection Fraction and Implantable Cardioverter Defibrillator. J. Clin. Med. 2020, 9, 1111. [Google Scholar] [CrossRef] [PubMed]
- Russo, V.; Rago, A.; Ciardiello, C.; Russo, M.G.; Calabrò, P.; Politano, L.; Nigro, G. The Role of the Atrial Electromechanical Delay in Predicting Atrial Fibrillation in Myotonic Dystrophy Type 1 Patients. J. Cardiovasc. Electrophysiol. 2016, 27, 65–72. [Google Scholar] [CrossRef] [PubMed]
- Schillinger, D. The Intersections Between Social Determinants of Health, Health Literacy, and Health Disparities. Stud. Health Technol. Inform. 2020, 269, 22–41. [Google Scholar] [CrossRef] [PubMed]
- Caturano, A.; Rocco, M.; Tagliaferri, G.; Piacevole, A.; Nilo, D.; Di Lorenzo, G.; Iadicicco, I.; Donnarumma, M.; Galiero, R.; Acierno, C.; et al. Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications. Antioxidants 2025, 14, 72. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Caturano, A. Cardiovascular and Metabolic Disease: New Treatment and Future Directions—The 3rd Edition. Biomedicines 2025, 13, 1914. https://doi.org/10.3390/biomedicines13081914
Caturano A. Cardiovascular and Metabolic Disease: New Treatment and Future Directions—The 3rd Edition. Biomedicines. 2025; 13(8):1914. https://doi.org/10.3390/biomedicines13081914
Chicago/Turabian StyleCaturano, Alfredo. 2025. "Cardiovascular and Metabolic Disease: New Treatment and Future Directions—The 3rd Edition" Biomedicines 13, no. 8: 1914. https://doi.org/10.3390/biomedicines13081914
APA StyleCaturano, A. (2025). Cardiovascular and Metabolic Disease: New Treatment and Future Directions—The 3rd Edition. Biomedicines, 13(8), 1914. https://doi.org/10.3390/biomedicines13081914